ICYMI: More Steps Required for Experimental ADPKD Drug in Order to Obtain Orphan Designation
<a href="https://pixabay.com/users/TeroVesalainen/">TeroVesalainen</a> / Pixabay

ICYMI: More Steps Required for Experimental ADPKD Drug in Order to Obtain Orphan Designation

According to a story from thenewsreports.com, the biopharmaceutical company XORTX Therapeutics, Inc., recently announced that the company and its partner Cato Clinical Research have received correspondence from the US Food…

Continue Reading
Close Menu